Liao Y, Xiong S, Ur Rehman Z, He X, Peng H, Liu J
Cancers (Basel). 2023; 15(1).
PMID: 36612296
PMC: 9818631.
DOI: 10.3390/cancers15010300.
Sun S, Liu H, Hu Y, Wang Y, Zhao M, Yuan Y
Bioact Mater. 2022; 20:166-178.
PMID: 35663338
PMC: 9157180.
DOI: 10.1016/j.bioactmat.2022.05.016.
Alves Ferreira-Bravo I, DeStefano J
Viruses. 2021; 13(10).
PMID: 34696413
PMC: 8539646.
DOI: 10.3390/v13101983.
Shukla A, Dwivedi-Agnihotri H
Adv Cancer Res. 2020; 145:139-156.
PMID: 32089163
PMC: 7115872.
DOI: 10.1016/bs.acr.2020.01.001.
Maio G, Enweronye O, Zumrut H, Batool S, Van N, Mallikaratchy P
ChemistrySelect. 2017; 2(7):2335-2340.
PMID: 29226219
PMC: 5716488.
DOI: 10.1002/slct.201700359.
NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.
Lin T, Pajarinen J, Lu L, Nabeshima A, Cordova L, Yao Z
Adv Protein Chem Struct Biol. 2017; 107:117-154.
PMID: 28215222
PMC: 5538562.
DOI: 10.1016/bs.apcsb.2016.11.002.
Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins.
Zumrut H, Ara M, Fraile M, Maio G, Mallikaratchy P
Nucleic Acid Ther. 2016; 26(3):190-8.
PMID: 27148897
PMC: 4900185.
DOI: 10.1089/nat.2016.0611.
Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
Binzel D, Shu Y, Li H, Sun M, Zhang Q, Shu D
Mol Ther. 2016; 24(7):1267-77.
PMID: 27125502
PMC: 5088763.
DOI: 10.1038/mt.2016.85.
Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders.
Dang L, Liu J, Li F, Wang L, Li D, Guo B
Int J Mol Sci. 2016; 17(3):428.
PMID: 27011176
PMC: 4813278.
DOI: 10.3390/ijms17030428.
Selection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity.
Alves Ferreira-Bravo I, Cozens C, Holliger P, DeStefano J
Nucleic Acids Res. 2015; 43(20):9587-99.
PMID: 26476448
PMC: 4751925.
DOI: 10.1093/nar/gkv1057.
Tunable Riboregulator Switches for Post-transcriptional Control of Gene Expression.
Krishnamurthy M, Hennelly S, Dale T, Starkenburg S, Marti-Arbona R, Fox D
ACS Synth Biol. 2015; 4(12):1326-34.
PMID: 26165796
PMC: 6849397.
DOI: 10.1021/acssynbio.5b00041.
A combined enrichment and aptamer pulldown assay for Francisella tularensis detection in food and environmental matrices.
Lamont E, Wang P, Enomoto S, Borewicz K, Abdallah A, Isaacson R
PLoS One. 2014; 9(12):e114622.
PMID: 25536105
PMC: 4275185.
DOI: 10.1371/journal.pone.0114622.
Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest.
Dai H, Ye M, Peng M, Zhou W, Bai H, Xiao X
Tumour Biol. 2014; 35(8):7561-8.
PMID: 24792887
DOI: 10.1007/s13277-014-1920-2.
Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth.
Kotula J, Sun J, Li M, Pratico E, Fereshteh M, Ahrens D
PLoS One. 2014; 9(4):e93441.
PMID: 24736311
PMC: 3988186.
DOI: 10.1371/journal.pone.0093441.
Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments.
Binzel D, Khisamutdinov E, Guo P
Biochemistry. 2014; 53(14):2221-31.
PMID: 24694349
PMC: 4004221.
DOI: 10.1021/bi4017022.
Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
Shu Y, Shu D, Haque F, Guo P
Nat Protoc. 2013; 8(9):1635-59.
PMID: 23928498
PMC: 3883045.
DOI: 10.1038/nprot.2013.097.
Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y, Haque F, Shu D, Li W, Zhu Z, Kotb M
RNA. 2013; 19(6):767-77.
PMID: 23604636
PMC: 3683911.
DOI: 10.1261/rna.037002.112.
Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers.
Haque F, Shu D, Shu Y, Shlyakhtenko L, Rychahou P, Evers B
Nano Today. 2012; 7(4):245-257.
PMID: 23024702
PMC: 3458310.
DOI: 10.1016/j.nantod.2012.06.010.
DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers.
Lai Y, DeStefano J
Nucleic Acid Ther. 2012; 22(3):162-76.
PMID: 22554064
PMC: 3423876.
DOI: 10.1089/nat.2011.0327.
Generating aptamers by cell-SELEX for applications in molecular medicine.
Ye M, Hu J, Peng M, Liu J, Liu J, Liu H
Int J Mol Sci. 2012; 13(3):3341-3353.
PMID: 22489154
PMC: 3317715.
DOI: 10.3390/ijms13033341.
